Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making

Academic Article
Publication Date:
2022
Short description:
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making / Marchegiani, G., Crippa, S., Perri, G., Rancoita, P.M.V., Caravati, A., Belfiori, G., Dall'Olio, T., Aleotti, F., Partelli, S., Bassi, C., Falconi, M., Salvia, R.. - In: ANNALS OF SURGICAL ONCOLOGY. - ISSN 1068-9265. - 29:5(2022), pp. 3206-3214. [10.1245/s10434-022-11326-5]
abstract:
Background Decision-making in intraductal papillary mucinous neoplasms (IPMNs) of the pancreas depends on scaling the risk of malignancy with the surgical burden of a pancreatectomy. This study aimed to develop a preoperative, disease-specific tool to predict surgical morbidity for IPMNs. Methods Based on preoperative variables of resected IPMNs at two high-volume institutions, classification tree analysis was applied to derive a predictive model identifying the risk factors for major morbidity (Clavien-Dindo >= 3) and postoperative pancreatic insufficiency. Results Among 524 patients, 289 (55.2%) underwent pancreaticoduodenectomy (PD), 144 (27.5%) underwent distal pancreatectomy (DP), and 91 (17.4%) underwent total pancreatectomy (TP) for main-duct (18.7%), branch-duct (12.6%), or mixed-type (68.7%) IPMN. For 98 (18.7%) of the patients, major morbidity developed. The classification tree distinguished different probabilities of major complications based on the type of surgery (area under the surve [AUC] 0.70; 95% confidence interval [CI], 0.63-0.77). Among the DP patients, the presence of preoperative diabetes identified two risk classes with respective probabilities of 5% and 25% for the development of major morbidity, whereas among the PD/TP patients, three different classes with respective probabilities of 15%, 20%, and 36% were identified according to age and body mass index (BMI). Overall, history of diabetes, age, and cyst size segregated three different risk classes for new-onset/worsening diabetes. Conclusions In presumed IPMNs, the disease-specific risk of major morbidity and pancreatic insufficiency can be determined in the preoperative setting and used to personalize the possible surgical indication. Age and overweight status in case of PD/TP and diabetes in case of DP tip the scale toward less aggressive clinical management in the absence of features suggestive for malignancy.
Iris type:
1.1 Articolo in rivista
Keywords:
Humans; Pancreas; Pancreatectomy; Retrospective Studies; Carcinoma, Pancreatic Ductal; Exocrine Pancreatic Insufficiency; Pancreatic Intraductal Neoplasms; Pancreatic Neoplasms
List of contributors:
Marchegiani, Giovanni; Crippa, Stefano; Perri, Giampaolo; Rancoita, Paola M V; Caravati, Andrea; Belfiori, Giulio; Dall'Olio, Tommaso; Aleotti, Francesca; Partelli, Stefano; Bassi, Claudio; Falconi, Massimo; Salvia, Roberto
Authors of the University:
CRIPPA STEFANO
FALCONI MASSIMO
PARTELLI STEFANO
RANCOITA PAOLA MARIA VITTORIA
Handle:
https://iris.unisr.it/handle/20.500.11768/132029
Published in:
ANNALS OF SURGICAL ONCOLOGY
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.2.0